Baxter 0.9% Sodium Chloride Injection recalled for fiberglass particulate matter
What this means
Baxter is recalling two lots of 0.9% Sodium Chloride Injection (saline solution) used in hospitals and dialysis centers because fiberglass particles have been found in the solution. The affected lots were distributed to hospitals and medical suppliers in 14 states between July 31 and August 3, 2026. No injuries have been reported so far.
- If you work at a hospital or dialysis center, immediately stop using the affected lots (Y495523 and Y495523A, expiring October 31, 2027).
- Contact Baxter at 888-229-0001 (Mon–Fri, 7 a.m.–6 p.m. Central Time) for return instructions.
- If a patient may have received this product, contact their physician or healthcare provider right away.
- Report any health problems related to this product to the FDA's MedWatch program at fda.gov/medwatch/report.htm or 1-800-332-1088.
Product photos
The agency's original wording
FOR IMMEDIATE RELEASE – AUG. 25, 2026 – DEERFIELD, Ill., Baxter International Inc. (NYSE:BAX) is voluntarily recalling two lots of 0.9% Sodium Chloride Injection due to the potential presence of particulate matter identified as fiberglass in the solution.
Official notice
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/baxter-issues-voluntary-nationwide-recall-two-lots-09-sodium-chloride-injection-due-potentialMore Baxter recalls
Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.